EIP
BIIB icon

Easterly Investment Partners’s Biogen BIIB Stock Holding History

Easterly Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-41,942
Closed -$9.04M – 201
2024
Q1 		$9.04M Buy
41,942
+36,858
+725% +$8.63M 0.69% 57
2023
Q4 		$1.32M Sell
5,084
-1,778
-26% -$437K 0.14% 126
2023
Q3 		$1.76M Sell
6,862
-27
-0.4% -$7.22K 0.19% 106
2023
Q2 		$1.96M Hold
6,889
– – 0.17% 110
2023
Q1 		$1.92M Buy
6,889
+96
+1% +$26.6K 0.17% 110
2022
Q4 		$1.88M Buy
6,793
+1,995
+42% +$563K 0.16% 112
2022
Q3 		$1.28M Sell
4,798
-1,334
-22% -$283K 0.12% 123
2022
Q2 		$1.25M Sell
6,132
-8,728
-59% -$1.78M 0.11% 126
2022
Q1 		$3.13M Sell
14,860
-15,635
-51% -$3.4M 0.24% 86
2021
Q4 		$7.32M Sell
30,495
-976
-3% -$251K 0.53% 70
2021
Q3 		$8.91M Buy
+31,471
New +$10.3M 0.6% 60

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Easterly Investment Partners's BIIB Position: Q2 2024 in Review

Easterly Investment Partners sold out of Biogen (BIIB) in Q2 2024, closing a stake of 41,942 shares — an estimated $9.04M sold.

Easterly Investment Partners first reported a position in BIIB in Q3 2021 and held it in 11 quarters. The position peaked at $9.04M in Q1 2024. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Easterly Investment Partners reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • Easterly Investment Partners sold 41,942 Biogen shares in Q2 2024, an estimated $9.04M.
  • Easterly Investment Partners first reported a position in Biogen in Q3 2021 and held it in 11 quarters.
  • Easterly Investment Partners's Biogen position peaked at $9.04M in Q1 2024.
  • 944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Easterly Investment Partners's 13F filing for Q2 2024, filed 25 Jul 2024.